Iradimed (IRMD) Total Liabilities (2013 - 2026)

Iradimed (IRMD) has 14 years of Total Liabilities data on file, last reported at $15.9 million in Q1 2026.

• Total Liabilities for Q1 2026 came in at $15.9 million, up 35.97% year-over-year; the trailing twelve-month figure through Mar 2026 was $15.9 million (up 35.97% YoY), and the FY2025 annual result was $14.2 million, up 23.04% from the prior year.
• Total Liabilities improved to $15.9 million in Q1 2026 per IRMD's latest filing, from $14.2 million in the prior quarter.
• Over five years, Total Liabilities peaked at $20.7 million in Q4 2023 and troughed at $9.8 million in Q3 2022.
• A 5-year average of $12.5 million and a median of $11.8 million in 2022 frame the typical range for Total Liabilities.
• The sharpest annual moves came in 2023 and 2024: Total Liabilities surged 75.12% in 2023, then sank 44.51% in 2024.
• A 5-year view of Total Liabilities shows it stood at $11.8 million in 2022, then surged by 75.12% to $20.7 million in 2023, then slumped by 44.51% to $11.5 million in 2024, then grew by 23.04% to $14.2 million in 2025, then increased by 12.13% to $15.9 million in 2026.
• Business Quant data shows IRMD's Total Liabilities at $15.9 million in Q1 2026, $14.2 million in Q4 2025, and $16.4 million in Q3 2025.